Predicting the response to levodopa.
D002114:Calcinosis / Q000188:drug therapy; D002196:Capillaries; D002490:Central Nervous System / Q000187:drug effects; D002555:Cerebrospinal Fluid / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010279:Parathyroid Diseases / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism; D010648:Phenylacetates / Q000378:metabolism; D010830:Physostigmine / Q000008:administration & dosage; D011339:Probenecid / Q000378:metabolism; D011379:Prognosis
D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D010830:Physostigmine; D011339:Probenecid